bims-cytox1 Biomed News
on Cytochrome oxidase subunit 1
Issue of 2026–11–01
five papers selected by
Gavin McStay, Liverpool John Moores University



  1. Diabetes Metab Syndr Obes. 2026 ;19 639810
      Diabetic kidney disease (DKD) remains a leading cause of chronic kidney disease and kidney failure despite major therapeutic advances. Current disease-modifying therapies reduce, but do not abolish, residual risk, indicating that additional cell-intrinsic mechanisms convert diabetic metabolic stress into progressive renal injury. Mitochondrial dysfunction has emerged as a central node in this process because renal tubular cells, podocytes, endothelial cells, and mesangial cells rely on mitochondrial oxidative phosphorylation to sustain transport, filtration-barrier integrity, redox control, and adaptive repair. Copper is an essential metal cofactor for cytochrome c oxidase (COX; respiratory chain complex IV), and mitochondrial copper delivery is required for COX assembly, electron transfer, proton-pumping capacity, and ATP generation. This review integrates established evidence from DKD pathobiology, mitochondrial biology, and copper homeostasis with emerging and indirect evidence to examine mitochondrial copper dyshomeostasis as a potential mechanistic link in DKD. Established findings support mitochondrial dysfunction in DKD and the essential role of copper in COX/complex IV assembly and respiratory-chain function. We further propose that diabetic metabolic stress may disturb copper uptake, intracellular trafficking, mitochondrial copper delivery, or copper use by COX, resulting in functional mitochondrial copper depletion or misallocation. Such disturbances could contribute to COX dysfunction, oxidative phosphorylation failure, ATP depletion, mtROS amplification, impaired mitochondrial quality control, and subsequent renal injury. However, direct DKD-specific evidence demonstrating impaired mitochondrial copper trafficking or functional mitochondrial copper depletion remains limited, and this mechanism should therefore be regarded as a testable hypothesis rather than an established pathogenic pathway. We also distinguish this mechanism from cuproptosis, examine intersections with ferroptosis, and outline biomarker, multi-omics, metallomics, and therapeutic opportunities.
    Keywords:  copper trafficking; cytochrome c oxidase; diabetic kidney disease; mitochondrial copper homeostasis; oxidative stress; renal injury; respiratory chain dysfunction
    DOI:  https://doi.org/10.2147/DMSO.S639810
  2. Ann N Y Acad Sci. 2026 Nov;pii: e70440. [Epub ahead of print]1565(1):
      Cardiac mitochondrial dysfunction contributes to hypertensive remodeling, but whether respiratory supercomplex organization preserves electron transfer efficiency during disease progression remains unresolved. Here, we examined the structural and functional organization of the respiratory complexes in cardiac mitochondria from stroke-resistant and stroke-prone spontaneously hypertensive rats exposed to normal or Japanese diet regimens. In both models, supramolecular analyses revealed the persistence of N-respirasome and Q-respirasome assemblies, indicating that major respiratory supercomplex species are maintained during sustained hypertension and in the pre-stroke state. However, metabolic flux control analysis consistently showed that cytochrome c oxidase or Complex IV exerted only limited control over respiratory flux, with control coefficients below those expected for tightly channeled nicotinamide adenine dinucleotide (NADH)-dependent electron transfer. Thus, structural preservation of respirasomes was not matched by evidence of kinetically optimized coupling. These findings uncouple supercomplex detectability from functional electron channeling and suggest that, in the hypertensive heart, respiratory performance is constrained by qualitative defects in supercomplex organization rather than by their overt loss.
    Keywords:  cardiac mitochondria; cytochrome c oxidase; electron flux control; respiratory supercomplexes; spontaneously hypertensive rats
    DOI:  https://doi.org/10.1111/nyas.70440
  3. Int J Mol Sci. 2026 Oct 13. pii: 9075. [Epub ahead of print]27(20):
      The intracellular pool of nicotinamide adenine dinucleotide phosphate (NADPH) is a limited resource for which multiple enzyme systems compete. Among these systems, microsomal NADPH-cytochrome P450 oxidoreductase (CPR, POR) plays a central role in electron transfer to cytochrome P450 enzymes and can also reduce other redox-active electron acceptors in vitro. This review analyzes the molecular basis of competition between CPR-mediated cytochrome P450 reduction and cytochrome c reduction in vitro and discusses whether this can be extrapolated to an indirect interplay between CPR and cytochrome c oxidase (COX) in intact cells. In vitro, reduced cytochrome c (Fe2+) acts as a competitive inhibitor of NADPH-dependent cytochrome P450 reduction, apparently by binding to an overlapping site on CPR. However, CPR and COX are physically separated by subcellular compartmentalization, and cytosolic and mitochondrial NADPH pools are largely separate; therefore, CPR and COX should not be considered direct competitors for a common NADPH pool under physiological conditions. Potential pharmacological implications include modulation of drug metabolism, cellular energy homeostasis, and toxicity when both systems are challenged, but these remain hypothetical and require direct flux measurements in intact cells.
    Keywords:  NADPH; NADPH shuttles; compartmentalization; cytochrome P450 oxidoreductase; cytochrome c oxidase; drug metabolism; electron transfer
    DOI:  https://doi.org/10.3390/ijms27209075
  4. Sci Adv. 2026 Oct 30. 12(44): eaed1177
      Hypoxia-inducible factors (HIFs) are constitutively active in clear cell renal cell carcinoma (ccRCC) cells. Here, we investigated whether these cells could still respond to hypoxia independently of canonical HIF activation. We found that hypoxia provokes a NADH reductive stress that attenuates lactate release when the supply of extracellular pyruvate becomes limited, a response that was restored by the ectopic expression of the cytosolic and mitochondria-targeted NADH oxidase (LbNOX). Suppression of the mitochondrial electron transport chain (mtETC) alone is sufficient to attenuate glycolytic flux when extracellular pyruvate is limited, a situation consistent with metabolomic data from human ccRCCs. Furthermore, this response can be mimicked by pharmacological or genetic inhibition of mitochondrial complex IV (CIV) activity and restored by the mitochondrial-targeted alternative oxidase (AOX). Therefore, our data suggest that cells can respond to low oxygen tension through a mitochondrial-dependent elevation of NADH/NAD+, resulting in the suppression of glycolysis when pyruvate availability is compromised.
    DOI:  https://doi.org/10.1126/sciadv.aed1177
  5. Mol Psychiatry. 2026 Oct 30.
      Mitochondrial complex IV (CIV) is an integral part of the mitochondrial electron transport chain (ETC) and plays a pivotal role in maintaining mitochondrial function. In contrast to the long-standing recognition of its dysfunction in Alzheimer's disease (AD), the exact role of CIV deficit in the pathogenesis of this neurodegenerative disorder remains poorly defined. In this study, by incorporating clinical resources, mouse- and human-based models of AD risk, and a genetic approach to bypass defective CIV via the ectopic expression of alternative oxidase (AOX), we examined whether CIV deficits are a pathogenic driver of or a beneficial adaptation to AD-associated pathologies. Our results showed a clinicopathological association between neuronal CIV dysfunction and pathological characteristics of AD. Further experiments linked defective CIV to the development of mitochondrial dysfunction and synaptic loss in the tested mouse- and human-based models of AD risk. In addition, a reciprocal relationship between CIV dysfunction and amyloid pathology was determined. Lastly, a proteome-wide association study (PWAS) using genetic data from large-scale AD cohorts identified that downregulation of COX11, a crucial CIV assembly factor, confers susceptibility to AD risk. Collectively, our findings suggest that CIV dysfunction is a detrimental pathology contributing to AD-associated mitochondrial and neuronal damage. The dual role of CIV dysfunction, both as a consequence of and a contributor to amyloid toxicity in AD pathogenesis, further justifies the therapeutic potential of strategies targeting CIV deficits to diversify the tools for prevention and treatment of this neurodegenerative disorder.
    DOI:  https://doi.org/10.1038/s41380-026-03935-3